Navigation Links
Remedium Technologies Inc. Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding
Date:4/16/2013

COLLEGE PARK, Md., April 16, 2013 /PRNewswire-USNewswire/ -- Remedium Technologies Inc., a medical device company developing innovative products to control severe hemorrhaging, was awarded a $500,000 Small Business Innovation Research (SBIR) grant from the National Science Foundation to test the company's sprayable foam for rapidly halting traumatic bleeding, company officials announce today.

In collaboration with Massachusetts General Hospital and the University of Maryland, Remedium will complete pre-clinical trials to evaluate the safety and efficacy of Hemogrip™ Foam in controlling non-compressible hemorrhaging, i.e., bleeding not accessible to direct pressure.  Hemogrip™ is a high-pressure, sprayable foam that can expand into an injured body cavity, adhere to tissue and stop hemorrhaging within minutes during the expansion process. There are currently no hemostatic products available for treatment of non-compressible bleeds, which account for 85 percent of hemorrhage-related deaths.

"Remedium is honored to be recognized for its product development progress with this important Phase II funding from the National Science Foundation," said Matthew Dowling , CEO and co-founder of Remedium. "We are enthusiastic in approaching pre-clinical trials with a product we see as critical in addressing non-compressible hemorrhage, which is one of the biggest unmet needs in trauma medicine today."

Hemogrip's™ life-saving technology is based on chitosan—a natural biopolymer found in the exoskeleton of shrimp, crabs, and other crustaceans. Chitosan is unique as a natural material because it is biocompatible, anti-microbial, and highly durable under a wide range of environmental conditions. When applied to wounds, Hemogrip™ creates a nano-scale, three-dimensional mesh, rapidly coagulating blood and staunching blood loss.

The Hemogrip™ Foam is dispensed from a handheld, lightweight canister that is easy to use by surgeons, soldiers and consumers alike. It can be removed quickly and easily without damaging tissue, and since it is based on chitosan—the second most abundant biopolymer on earth—it is also inexpensive.

Remedium was previously awarded a $150,000 SBIR Phase I grant from NSF to demonstrate the biological proof-of-concept of the sprayable foam. The company was also recently awarded a $200,000 Translational Research Award from the Maryland Biotechnology Center.

The company has six patents pending related to the Hemogrip™ platform.

About Remedium Technologies Inc.
Remedium Technologies is a medical device start-up that operates with a vision of user-directed advancement in the standard of care for the control of severe hemorrhage. The principals of Remedium Technologies have created a proprietary life-saving technology called Hemogrip™ which acts to stop traumatic bleeding rapidly. As the active component in a suite of pipeline products under development, Hemogrip™ is a uniquely user-friendly hemostat which is able to orchestrate the self-assembly of a clot-like seal upon contact with blood. It can be used effectively by a surgeon, by a soldier, or by an unskilled "buddy." Working under grants from the National Science Foundation and the United States Army Research Lab, Remedium Technologies is dedicated to saving lives both in the field and in the operating room.


'/>"/>
SOURCE Remedium Technologies Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
2. Multisorb Technologies Non-Toxic StabilOx Oxygen Absorbing Canisters Provide Worry-Free Drug Stability
3. Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.
4. Advances in Surgical Technologies Boost Demand for Efficient Bone Graft Substitutes, Finds Frost & Sullivan
5. Cantel Medicals Mar Cor Purification Subsidiary Acquires Hemodialysis Water Business from Siemens Water Technologies Business Unit
6. SafeCode Drug Technologies Initiating Activities to Commercialize its Recent Newly Acquired Technology of the Pain-Free Injection
7. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
8. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
9. Patient Safety Technologies Reports Fourth Quarter And Fiscal 2012 Results
10. Medbox Acquires 50% of MedVend and its Patented Technologies
11. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced ... comparisons, unless otherwise noted, are to the quarter ended June ... Quarter 2017 Highlights include: Revenue of ... Total prescriptions dispensed of 220,000, compared to ... Gross profit per prescription dispensed of ...
(Date:8/3/2017)...  Opioid addiction and other drugs of abuse, blood ... threatening outcomes, were problems taken on directly as laboratory ... support them, met this week. This according to Kalorama ... of abuse, procalcitonin and acute kidney injury were key ... meeting in San Diego, CA. ...
(Date:8/2/2017)... Aug. 2, 2017 CaryRx, a next-generation full-service pharmacy, ... service for patients in the Washington D.C. ... pharmacy by providing delivery of medications through the convenience of ... delivery or delivered within one hour to any location in ... to bring this invaluable service to Washington D.C. ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... 2017 , ... “Kingdom Mandate for Kingdom Builders”: a call to walk as ... Builders” is the creation of published author, John F. McGeorge, Jr. Dr. John ... in 1983. He spent three decades training pastors and Christian leaders. He ...
(Date:8/18/2017)... ... 2017 , ... “Steve the Snake”: an entertaining and moral-based short story about ... published author, Harold Flash Haskins Jr., a husband, father and grandfather who served as ... “I write moral-based short stories for children and teens. My goal is to teach ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... practice, is adding a new location in Goldsboro, NC to its family of ... that is Riccobene Associates’ trademark starting August 15, 2017. , Riccobene Associates ...
(Date:8/17/2017)... ... August 17, 2017 , ... The award-winning producers ... feature the National Council for Therapeutic Recreation Certification (NCTRC), slated to air nationwide, ... 1981, NCTRC is a non-profit, international organization dedicated to professional excellence for the ...
(Date:8/17/2017)... Boston, MA (PRWEB) , ... August 17, 2017 ... ... investors will come together on September 19, 2017 for Anti-Infectives Rx. This off-the-record ... Joseph B. Martin Conference Center at Harvard Medical School. , Industry leaders and ...
Breaking Medicine News(10 mins):